SUMO2 anticorps

N° du produit ABIN1882280

Détail du produit anti-SUMO2 anticorps

Antigène: SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))

Reactivité: Humain, Rat

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp SUMO2 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF)

Homologie: B, C, Ha, Pr, M, Pig

Purification: This antibody is purified through a protein G column, followed by dialysis against PBS.

Immunogène: Purified His-tagged SUMO2 protein was used to produced this monoclonal antibody.

Clone: 973CT8-1-1

Isotype: IgG2b

Information d'application

Indications d'application: IF: 1:25. WB: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified monoclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Références pour anticorps anti-SUMO2 (ABIN1882280)

Xu, Au: "Mapping residues of SUMO precursors essential in differential maturation by SUMO-specific protease, SENP1." dans: The Biochemical journal, Vol. 386, Issue Pt 2, pp. 325-30, (2005) (PubMed).

Reverter, Lima: "A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex." dans: Structure (London, England : 1993), Vol. 12, Issue 8, pp. 1519-31, (2004) (PubMed).

Mannen, Tseng, Cho, Li: "Cloning and expression of human homolog HSMT3 to yeast SMT3 suppressor of MIF2 mutations in a centromere protein gene." dans: Biochemical and biophysical research communications, Vol. 222, Issue 1, pp. 178-80, (1996) (PubMed).

Détails sur SUMO2

Antigène: SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))

Autre désignation: SUMO2 (SUMO2 Produits)

Synonymes: anticorps HSMT3, anticorps SMT3B, anticorps SMT3H2, anticorps SUMO3, anticorps Smt3A, anticorps SMT3A, anticorps SMT3H1, anticorps SUMO-3, anticorps Smt3B, anticorps Smt3h2, anticorps sumo2, anticorps zgc:92241, anticorps SUMO2, anticorps SUMO-2, anticorps Smt3b, anticorps hsmt3, anticorps smt3b, anticorps smt3h2, anticorps sumo-2, anticorps PSMT3, anticorps ATSUMO2, anticorps MCO15.11, anticorps MCO15_11, anticorps SMALL UBIQUITIN-LIKE MODIFIER 2, anticorps SUM2, anticorps SUMO 2, anticorps small ubiquitin-like modifier 2, anticorps small ubiquitin-like modifier 2, anticorps small ubiquitin-like modifier 3, anticorps small ubiquitin-like modifier 2b, anticorps small ubiquitin-related modifier 2, anticorps small ubiquitin-like modifier 2 S homeolog, anticorps small ubiquitin-like modifier 2 L homeolog, anticorps SUMO2, anticorps SUMO3, anticorps Sumo2, anticorps sumo2b, anticorps LOC714892, anticorps sumo2.S, anticorps sumo2.L

Sujet: Ubiquitin-like protein that can be covalently attached to proteins as a monomer or as a lysine-linked polymer. Covalent attachment via an isopeptide bond to its substrates requires prior activation by the E1 complex SAE1-SAE2 and linkage to the E2 enzyme UBE2I, and can be promoted by an E3 ligase such as PIAS1-4, RANBP2 or CBX4. This post-translational modification on lysine residues of proteins plays a crucial role in a number of cellular processes such as nuclear transport, DNA replication and repair, mitosis and signal transduction. Polymeric SUMO2 chains are also susceptible to polyubiquitination which functions as a signal for proteasomal degradation of modified proteins.

Poids moléculaire: 10871

NCBI Accession: NP_001005849, NP_008868

UniProt: P61956

Pathways: Methionine Biosynthetic Process